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1. Introduction 
The toxin, produced by Vibrio cholerae, is an 
84 000 mol. wt protein [I], composed of three unique 
polypeptide chains (Y, 0,~ and has a molecular formula 
I& [2-41. The (Y and 7 chains are linked through a 
single disulfide bond, forming protomer A. Five 
identical polypeptide chains form a stable aggregate, 
protomer B. Protomer A and B are very tightly bound 
and can be dissociated slowly with detergents. Treat- 
ment of the toxin with dithiothreitol gives selective 
reduction of the disulfide bond linking two distinct 
functional regions, fragment (Y and fragment 7pS [5,6]. 
Although devoid of any catalytic activity fragment rpS 
nevertheless retains the ability of the intact toxin to 
recognize the cell surface receptor, the monosialo- 
ganglioside sl. Exposure to the solvent of the 
catalitically active region of the OL chain, after reduc- 
tion, enables it to stimulate adenylate cyclase. 
The time course of activation of adenylate cyclase 
in intact relative to broken cells has shown that there 
is a lag period between the initial binding step of the 
toxin to intact cells and the final cyclase activation 
step [7-91. Studies with fluorescent probes and 
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immunoelectron microscopy have provided evidence 
that the latent period may represent the time 
required for a redistribution of the toxin-receptor 
complexes in the cell membrane [ 10,111. Whether 
the active functional region penetrates the membrane 
through channels [ 121 or a change in the conforma- 
tion of the toxin [ 131, resulting from the mobility of 
the toxin--s1 complexes in the membrane, remains 
to be determined. At present, although some authors 
have reported an interaction of hydrophobic nature 
between protomer A and membranes [13,14], no 
direct evidence of the dissociation either of protomer 
A or of the (Y chain has been obtained, after binding 
of the toxin to biological membranes. In view of these 
observations, we examined the characteristic and 
specific binding of cholera toxin to vesicles con- 
taining GM1 [15] with respect to the possible inter- 
actions of the active (Y fragment with model mem- 
branes. The effect of binding on the reactivity of the 
interchain disulfide bond connecting the Q! and 7pS 
functional regions was also studied. 
This communication shows that the interaction of 
cholera toxin with GM1--vesicles is strong enough to 
induce perturbations in the lipid membrane but it 
does not affect the dissociation of the active (Y chain 
from the vesicle-bound toxin. 
2. Materials and methods 
Toxin was isolated as in [ 161. Gangliosides GM1 
and sla were isolated by the method in [ 171 and 
were >98% pure. Oligo-G,,, the oligosaccharide 
moiety of sl, was prepared by ozonolysis and 
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alkaline fragmentation [ 18,191. A constant amount 
of (&I and the amounts of phosphatidylcholine (egg 
yolk, Supelchem) necessary to give the C&-lipid 
ratios R 0.108 and 0.228 were utilized. Vesicles were 
prepared according to the method in 1201, isolated 
after gel filtration on a Sepharose 4B column 
(1.5 X 100 cm) and used throughout our experiments. 
The amount of ganglioside exposed to the solvent, 
on the outer-vesicle surface was determined by 
estimating N-acetylneuraminic acid [ 171 released 
after treatment of vesicles, prepared with GDla, with 
Vibrio cholerue neuraminidase (Serva, Heidelberg) 
and confirmed by the method in [20]. Vesicles were 
found to have mol. wt 2.3 f 0.3 X lo6 and 60% of 
sl, available for binding, exposed on the outer- 
vesicle surface. Binding was assayed by incubating 
the amounts of vesicles indicated in fig. 1 with cholera 
toxin (0.12 nmol) in 0.02 M Tris-HCI buffer 
(pH 8.2) 0.002 M EDTA, at 3O”C, for 5 min, in 
0.1 ml final vol. For inhibition experiments the same 
amount of toxin was incubated at 30°C, with the 
amount of vesicles containing 6.4 nmol Ghll on the 
outer-vesicle surface prior to the addition of 84 nmol 
oligo-Gl. Samples were analyzed by polyacrylamide 
disc-gel electrophoresis as in [5]. The bound toxin 
does not enter the gel. The unbound toxin was 
quantitated as in [5] and subtracted from the amount 
added to give the amount bound to vesicles. Non- 
specific binding was determined by incubating cholera 
toxin with sl-free vesicles. In control experiments 
identical amounts of unbound toxin were also 
recovered from the supernatant after centrifugation 
of the incubation mixtures at 250 000 X g for 3 h. 
Spectral measurements were made with the use 
of Yankeelow double-sector cells. The sample cell 
contained 1 ml vesicle dispersion in the first compart- 
ment and 1 ml cholera toxin (2.4 X 10m6 M) in the 
second compartment. The reference cell contained 
in the respective compartments the vesicle dispersion 
and the solvent buffer. Vesicle aggregation was 
measured by recording the turbidity of the vesicle- 
toxin mixtures, immediately after mixing of the 
double-sector cells, at 30°C and 400 nm, in a Varian 
Cary 118 recording spectrophotometer. 
Similar results for the binding experiments were 
also obtained with vesicles containing the amounts 
of GM1 and cholesterol described in [ 151 and are, 
therefore, not reported. 
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3. Results and discussion 
Figure 1 shows the results of experiments in which 
cholera toxin was added to vesicles with different 
G1--lipid molar ratios. Since all the toxin was 
recovered in the supernatant in the case of vesicles 
without C&l, in the conditions employed there was 
no significant entrapment of the toxin. At saturation 
each toxin molecule binds 1.7 and 5.3 molecules of 
membrane-bound sl, for R = 0.108 and 0.228, 
respectively. Apparently, a different localization of 
the ganglioside receptors less widely spaced, at higher 
Gl-lipid ratios, results in a lower binding affinity. 
When toxin was added to sl-vesicles, the 
absorbance increase, observed with longer incubation 
times, is presumably due to the formation of vesicle 
aggregates (fig.2), which resembles cell agglutination 
induced by lectins [21]. All the toxin added is bound 
to the vesicles within 5 min, while there is still no 
significant aggregation. The rate at which turbidity 
increased was dependent on ganglioside concentra- 
tion on the outer-vesicle surface and no aggregation 
was observed, under the same experimental condi- 
tions, with vesicles free of GM1. 
It has been shown that cholera toxin contains 
multiple binding sites (5-6) for the oligosaccharide 
nmol of GM, 
Fig.1. Binding of cholera toxin to GM1 -vesicles. Binding 
experiments were performed as in section 2. Results are 
expressed as percentage of protein bound. In the abscissa the 
amounts of GM1 present on the outer-vesicle surface are 
reported. (a-- - -0) R = 0.108; (o- o) R = 0.228. 
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Minutes 
Fig.2. Kinetics of aggregation of GMl-vesicles after addition 
of cholera toxin and reversibility of the binding in the 
presence of oligo-Gl,,iI. Aggregation was measured from the 
increase in turbidity at 400 nm. (- - -)R = 0.108; (-) 
R = 0.228. For the ~ibition experiments cholera toxin was 
incubated with G MI -vesicles for the times indicated prior to 
the addition of ollgoCMl. After 5 min, the mixture was 
analyzed as described in fig.1. (e- - -o)R = 0.108; 
to--- o) R = 0.228. 
laterally and vertically in the membrane, after incuba- 
tion for times comparable to those of our aggregation 
experiments [I I ]. Moreover the irreversibility of the 
binding at longer incubation times supports a
mechanism similar to the fusion process described for 
the interaction of lectins with liposomes [23]. No 
matter what kind of process takes place at the 
membrane, after toxin binding, either a diffusion of 
the toxin in the lipid matrix or a vesicle fusion, the 
subsequent s ructural or topological rearrangements 
may alter the reactivity of the interchain disulfide 
bond connecting cholera toxin functional regions. 
The kinetics of reduction of cholera toxin bound 
to GM1-vesicles i shown in fig.3. Comparison of the 
rates of reduction, under the same conditions, with 
free cholera toxin shows no effect of the binding to 
the model membranes on the reactivity of the disulfide 
bond. Although the lipid environment of the mem- 
brane affords partial protection against the characteristic 
dissociation-aggregation transition of the (Y chain 
[5,6], there was neither a specific interaction between 
the a chain and the membrane lipids, nor a diffusion 
moiety of ganglioside C&I [22]. At higher %,-lipid 
ratios, the density of the ol~go~c~ha~de moieties 
protruding out of the vesicle surface introduces teric 
constraints which will not allow the receptors of a 
single vesicle to become correctly positioned with 
respect o the toxin. Such a high density results in 
the formation of preferential bindings between the 
toxin and the receptors of different vesicles. At lower 
$r-lipid ratios all 5 toxin binding sites are pre- 
ferentially bound to the receptors of a single vesicle. 
The data of fig.1 appear to support his possibility; 
decreasing by 50% the density of the ganglioside on 
the vesicle surface allows each toxin molecule to bind 
5 molecules of C& instead of 2. 
When aggregation ccurs, addition of specific 
inhibitors, such as oligo-G1, reverses the process 
only in the early stages (fig.2). The reason for this 
may be that all toxin does not bind to C& in an 
equivalent manner since the time course of the binding 
process may be mediated by a different localization 
of GM1 in the membrane. A change in the topological 
distribution of receptor sites may be expected since it 
has been reported that cell-bound toxin diffuses both 
Minutes 
Fig.3. Dissociation of the Q chain from reduced cholera toxin 
bound to G h,Il-vesicles. Cholera toxin (0.24 nmol) was 
incubated for I h at 37°C with an amount of vesicles con- 
taining 5.5 nmol GM1 on the outer-vesicle surface. In control 
experiments the addition of vesicles was omitted. After the 
addition of 1 pmol dithiothreitol, aliquots of the samples 
were withdrawn and analyzed as in [S]. Results are expressed 
as percentage of the chain recovered from reduced samples, 
(o- - -0) cholera toxin; (* -0) cholera toxin plus 
vesicles. 
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of the active region itself into the vesicle membrane. 
In fact, the a chain can be quantitatively recovered 
also from f&y aggregated toxin-vesicle complexes, 
treated with dithiothreitol after several days or weeks 
of incubation. 
The results described here suggest that although 
GM1 may be an important part of the receptor for 
cholera toxin, it is not sufficient simply for $1 to 
be present in the membrane, because when the toxin 
becomes essentially irreversibIy attached to the 
membrane, the functional region can be still 
quantitatively removed by reduction. Thus, the ou 
active functional region seems to remain on the out- 
side of the vesicle membrane, xposed to the solvent, 
and other factors or regions of specificity may be 
invoIved in its penetration. 
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